We Are Attorneys, Not Doctors
Whitman Mesothelioma Law Firm is a law firm. Our attorneys have extensive experience with mesothelioma and asbestos cases, but we are not medical professionals. Medical content on this website is informational only and should not replace advice from qualified healthcare providers. Patients facing a mesothelioma diagnosis should seek care from oncologists and specialized mesothelioma treatment centers.
How We Research Medical Content
All medical claims on this website are researched from authoritative sources. We do not publish medical information based on general internet sources. Every medical statement traces to one or more of the following:
- National Cancer Institute (NCI) — The federal government authority on cancer research and statistics
- American Cancer Society (ACS) — Nonprofit organization providing authoritative cancer information
- SEER Program — The NCI Surveillance, Epidemiology, and End Results Program
- World Health Organization (WHO) and IARC — Global health authorities and cancer classifications
- Peer-reviewed medical journals — Including NEJM, JAMA, The Lancet, Journal of Thoracic Oncology, and Lung Cancer
- U.S. Food and Drug Administration (FDA) — Drug approvals and treatment indications
- OSHA and NIOSH — Workplace exposure data and occupational disease research
Medical Review Approach
While we do not currently employ staff physicians, we follow these practices to ensure medical accuracy:
- Source citation — Every medical statistic, treatment description, and prognosis claim is traceable to an authoritative source
- Conservative claims — When sources vary, we use more conservative figures or cite ranges
- Current FDA approvals — Treatment descriptions reflect current FDA-approved regimens (e.g., nivolumab + ipilimumab for mesothelioma, approved October 2020)
- Distinction of established vs. emerging — FDA-approved treatments are presented as established; Phase 2 trial results are clearly marked as research
- Professional consultation — We consult with mesothelioma oncologists and pathologists when developing significant new medical content
- Review cadence — Medical content is reviewed quarterly for accuracy and updated when new research, treatments, or statistics emerge
What Triggers Content Updates
- New FDA approvals of mesothelioma treatments
- New Phase 3 clinical trial results with practice-changing findings
- Annual updates to SEER cancer statistics
- New treatment guidelines from major oncology organizations (ASCO, NCCN)
- Significant regulatory changes (EPA, OSHA)
- User-reported inaccuracies
How This Content Should Be Used
The medical information on this website is designed to:
- Help patients and families understand mesothelioma
- Explain treatment options in accessible language
- Clarify the connection between asbestos exposure and disease
- Support legal understanding of medical aspects of cases
This content is NOT a substitute for:
- Medical consultation with an oncologist
- Evaluation at a specialized mesothelioma treatment center
- Individual treatment planning with your medical team
- Emergency medical care
Our Commitment
Mesothelioma patients and families deserve accurate medical information. We take this responsibility seriously and maintain the processes described above to ensure the content on this website reflects current, authoritative medical knowledge. If you identify any medical inaccuracy on this website, please contact us — we will review and correct errors promptly.